Patents by Inventor Peter Muschick

Peter Muschick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
    Publication number: 20110052492
    Abstract: This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention.
    Type: Application
    Filed: November 3, 2010
    Publication date: March 3, 2011
    Inventors: Matthias FRIEBE, Peter Muschick, Andreas Huth
  • Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
    Publication number: 20110027179
    Abstract: This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention.
    Type: Application
    Filed: October 14, 2010
    Publication date: February 3, 2011
    Inventors: Matthias FRIEBE, Peter Muschick, Andreas Huth
  • Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
    Patent number: 7850948
    Abstract: This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention.
    Type: Grant
    Filed: September 10, 2008
    Date of Patent: December 14, 2010
    Assignee: Bayer Schering Pharma AG
    Inventors: Matthias Friebe, Peter Muschick, Andreas Huth
  • Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
    Publication number: 20090012090
    Abstract: This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention.
    Type: Application
    Filed: September 10, 2008
    Publication date: January 8, 2009
    Inventors: Matthias Friebe, Peter Muschick, Andreas Huth
  • Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
    Patent number: 7427390
    Abstract: This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: September 23, 2008
    Assignee: Schering AG
    Inventors: Matthias Friebe, Peter Muschick, Andreas Huth
  • Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
    Publication number: 20050207972
    Abstract: This invention relates to new radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy. The radiohalogenated benzamide derivatives according to the invention exhibit novel and especially advantageous properties, in particular with respect to tumor concentration and retardation, liver concentration and blood accumulation. The radiation-therapy doses to be achieved in the tumor, compared to healthy body tissue, are advantageous for the compounds according to the invention.
    Type: Application
    Filed: March 10, 2005
    Publication date: September 22, 2005
    Inventors: Matthias Friebe, Peter Muschick, Andreas Huth
  • Radioactively coated stents
    Publication number: 20040241316
    Abstract: The invention relates to novel radioactive stents and to methods for the production thereof.
    Type: Application
    Filed: June 23, 2004
    Publication date: December 2, 2004
    Inventors: Ludger Dinkelborg, Peter Muschick, Bernard Noll, Heidemarie Goerner
  • Concentrated injection and infusion solution for intravenous administration
    Patent number: 6638913
    Abstract: Additives to concentrated injection and infusion solutions that avoid or mitigate acute or delayed hypersensitivity reactions as well as injection and infusion solutions that contain these additives are described.
    Type: Grant
    Filed: February 14, 2000
    Date of Patent: October 28, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Ulrich Speck, Gabriele Schuhmann-Giampieri, Peter Muschick, Werner Krause
  • Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particulate pharmaceutical preparations
    Patent number: 5874422
    Abstract: The use of nonsteroidal anti-inflammatory agents as an addition to particulate pharmaceutical agent preparations can reduce side-effects on the cardiovascular system during administration.
    Type: Grant
    Filed: January 27, 1998
    Date of Patent: February 23, 1999
    Assignee: Schering Aktiengesellschaft
    Inventors: Werner Krause, Peter Muschick
  • Iodine-containing peptides
    Patent number: 5756066
    Abstract: Iodine-containing peptides of general formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, a, m and q have the meanings indicated in the description, agents containing these compounds, the use of compounds as contrast media as well as processes for their production are described.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 26, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Danute Nitecki, Werner Krause, Franz-Karl Maier, Gabriele Schuhmann-Giampieri, Wolf-Rudiger Press, Peter Muschick, Sara Biancalana
  • 3-cyano-5,4'-bipyridine-1'-oxide compounds and pharmaceutical compositions and methods containing the same
    Patent number: 5162533
    Abstract: A 3-cyano-5,4'-bipyridine-1'-oxide of the formula ##STR1## and their pharmaceutically acceptable acid addition salts, wherein R is an amino, alkoxy, oxyalkoxy or chloro residue, have heart stimulating cardiotonic and vasodiolatory properties. They can be preparaed by (a) converting an R-substituted-3-cyano-bipyridine to its corresponding N-oxide, or (b) by substituting an R-residue or an R-unsubstituted precursor of the conpound of fomula (i), and if required, converting the product into its pharmaceutically acceptable acid addition salt.
    Type: Grant
    Filed: March 7, 1991
    Date of Patent: November 10, 1992
    Assignee: Arzneimittelwerk Dresden G.m.b.H.
    Inventors: Erhard Klauschenz, Volker Hagen, Angela Hagen, Peter Muschick, Brigitte Schlegel, Sabine Heer, Gottfried Faust, Hans-Joachim Jansch